Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Dl-alpha-tocopheryl acetate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for DL-alpha-tocopheryl acetate, the active ingredient of Vitamin E Suspension, is a man-made form of vitamin E. Although the exact role of vitamin E has not yet been worked out, it is known to play an important part in metabolism – the chemical reactions that are taking place in the body all the time. Vitamin E Suspension is used in certain illnesses which prevent the body from absorbing enough vitamin E from the diet. By taking extra vitamin E in the form of Vitamin E Suspension, the body gets all it needs. The medical names for these illnesses are cystic fibrosis (an inherited disorder affecting the lungs, pancreas and other glands), chronic cholestasis (a disease of the liver) and abetalipoproteinaemia (a rare inherited disease which causes a deficiency of fat in the blood and severely affects growth).
e Vitamin E Suspension Do not take Vitamin E Suspension:
Vitamin E PIL UK 008
Talk to your doctor or pharmacist before taking Vitamin E Suspension:
Vitamin E PIL UK 008
Polyoxyl castor oil may cause stomach upsets and diarrhoea. This medicine contains 10 mg benzoic acid in each 5ml. Benzoic acid may increase jaundice (yellowing of the skin and eyes) in newborn babies (up to 4 weeks old). This medicine contains 13.99 mg propylene glycol in each 5ml. If your baby is less than 4 weeks old, talk to your doctor or pharmacist before giving them this medicine, in particular if the baby is given other medicines that contain propylene glycol or alcohol.
Vitamin E Suspension Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The usual doses vary depending upon the age of the patient, the condition for which Vitamin E Suspension was prescribed, and sometimes also the patient's weight. Vitamin E blood levels will be checked by your doctor at regular intervals during treatment and the dose adjusted as necessary.
If you have any further questions on the use of this product ask your doctor or pharmacist.
4. Possible side effects Like all medicines Vitamin E Suspension can cause side-effects, although not everybody gets them. It is possible that you might develop diarrhoea or a stomach upset. Reporting of side effects If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report
directly via the internet at www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.
Vitamin E Suspension Keep this medicine out of the sight and reach of children – preferably in a locked cupboard or medicine cabinet. Do not use this medicine after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month. Do not use Vitamin E Suspension for more than one month after you have opened it. The product may be diluted with syrup BP, but should be used immediately and not stored. Do not store above 25oC. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Vitamin E Suspension contains The active substance is DL-alpha-tocopheryl acetate, and there is 100mg of this in each ml of your medicine. The other ingredients are benzoic acid E210, sorbic acid, glycerol, sucrose, raspberry flavour (containing propylene glycol E1520 and natural flavourings), polyoxyl castor oil and purified water. What Vitamin E Suspension looks like and contents of the pack Each bottle contains 100ml of Vitamin E Suspension.
Vitamin E PIL UK 008
Marketing Authorisation Holder Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB, UK. Manufacturer Laleham Health and Beauty Limited, Fairfield, Bradshaw Lane, Greenhalgh, Kirkham, Preston, Lancashire PR4 3JA. This leaflet was last revised in July 2024
Vitamin E PIL UK 008
Vitamin E Suspension 100mg/ml comes as oral solution containing 100mg/ml. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Vitamin E Suspension 100mg/ml is dl-alpha-tocopheryl acetate.
This leaflet reproduces the patient information leaflet approved for Vitamin E Suspension 100mg/ml, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the correction of Vitamin E deficiency occurring in malabsorption disorders ie. cystic fibrosis, chronic cholestasis and abetalipoproteinaemia.
Route of administration: For oral use.
Adults (including the elderly)
For the treatment of malabsorption disorders the following doses should be administered:
Cystic fibrosis
100-200mg/day
Abetalipoproteinaemia
50-100mg/kg/day
Children
For the treatment of cystic fibrosis a dose of 50mg/day should be given to children less than 1 year and 100mg/day to children 1 year and over. The dose should be adjusted to maintain serum α-tocopherol:cholesterol ratio above 5.4 mg/g. Serum levels should be monitored at least annually and 3-6 months after a dosage change.
The adult dosage should be used for the treatment of abetalipoproteinaemia (50-100mg/kg/day).
Infants with vitamin E deficiency which is secondary to chronic cholestasis may be treated with doses of 150-200mg/kg/day.
Vitamin E blood levels should be measured at regular intervals and doses adjusted accordingly.
For instructions on dilution of Vitamin E before administration, see section 6.6.
Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Vitamin E has been reported to increase bleeding tendency in vitamin-K deficient patients or those taking anticoagulant treatments, it is therefore recommended to monitor the prothrombin time and international normalised ratio (INR) to detect any changes in haemostasis. A possible adjustment of the dose of anticoagulants during and after treatment with Vitamin E Suspension 100 mg/ml may be necessary (see section 4.5).
Vitamin E has been reported to increase the risk of thrombosis in patients predisposed to this condition, including patients taking oestrogens. This finding has not been confirmed but should be borne in mind when selecting patients for treatment, in particular women taking oral contraceptives containing oestrogens.
A higher incidence of necrotising enterocolitis has been noted in lower weight premature infants (less than 1.5kg) treated with vitamin E.
Vitamin E Suspension 100mg/ml contains benzoic acid which may increase jaundice in newborn babies, and polyoxyl castor oil which may cause stomach upsets and diarrhoea. Vitamin E Suspension 100mg/ml also contains propylene glycol, therefore co-administration with any substrate for alcohol dehydrogenase such as ethanol may induce serious adverse effects in neonates. Vitamin E Suspension 100mg/ml also contains sucrose which may be harmful to the teeth; refer to section 4.3.
Serum levels of vitamin E should be monitored in cholestatic patients undergoing concurrent treatment with colestyramine (see section 4.5). The dose of vitamin E should be adjusted as necessary.
Vitamin E in dosages of greater than 4.5 mg/kg daily may delay the response to iron therapy in children with iron-deficiency anaemia. Iron concentrations should be monitored closely (see section 4.5).
Vitamin E may increase the risk of haemorrhage in patients taking anticoagulants (see section 4.4).
Vitamin E may increase the risk of thrombosis in patients taking oestrogens (see 4.4 above).
Colestyramine may reduce the absorption of vitamin E (see section 4.4).
Iron: Limited data suggest that excessive doses of vitamin E (>4.5 mg/kg/day) can delay the red blood cell response to iron supplements in severely anaemic infants, and that low-birth weight infants treated with iron supplements may develop vitamin E-deficiency haemolytic anaemia. High doses of vitamin E should be avoided in infants. It is not known if this interaction occurs in adults (see section 4.4).
There is no evidence of the safety of high doses of vitamin E in pregnancy nor is there evidence from animal work that it is free from hazard, therefore do not use in pregnancy especially in the first trimester. No information is available on excretion in breast milk, therefore it is advisable not to use during lactation.
None known.
Diarrhoea and abdominal pain may occur with doses greater than 1g daily.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
Transient gastro-intestinal disturbances have been reported with doses greater than 1g daily and where necessary, general supportive measures should be employed.
Ask anything about Vitamin E Suspension 100mg/ml. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.